Aptevo files prospectus supplement for ATM offering of up to $8.0M

Aptevo Therapeutics Inc.

Filed prospectus supplement for ATM offering of up to $8,037,381 in common stock via Roth Capital Partners.
As of June 20, had sold 481,828 shares for gross proceeds of $3,765,143 under the April 2025 Sales Agreement.
Offering is registered under Form S-3 (File No. 333-284969); legal opinion from Paul Hastings LLP filed as exhibit.

item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.